CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2025	Jun. 30, 2024
Current assets
Cash and cash equivalents	$ 167	$ 202
Receivables, net	821	695
Inventories, net	523	637
Prepaid expenses and other current assets	97	88
Total current assets	1,608	1,622
Property, plant and equipment, net	1,267	1,315
Operating lease right-of-use assets	333	360
Goodwill	1,229	1,228
Trademarks, net	502	538
Other intangible assets, net	64	143
Other assets	558	545
Total assets	5,561	5,751
Current liabilities
Notes and loans payable	4	4
Current operating lease liabilities	87	84
Accounts payable and accrued liabilities	1,828	1,486
Total current liabilities	1,919	1,574
Long-term debt	2,484	2,481
Long-term operating lease liabilities	305	334
Other liabilities	351	848
Deferred income taxes	20	22
Total liabilities	5,079	5,259
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of June 30, 2025 and 2024; and 122,694,263 and 124,201,807 shares outstanding as of June 30, 2025 and 2024, respectively	131	131
Additional paid-in capital	1,319	1,288
Retained earnings	432	250
Treasury stock, at cost: 8,047,198 and 6,539,654 shares as of June 30, 2025 and 2024, respectively	(1,404)	(1,186)
Accumulated other comprehensive net (loss) income	(157)	(155)
Total Clorox stockholders’ equity	321	328
Noncontrolling interests	161	164
Total stockholders’ equity	482	492
Total liabilities and stockholders’ equity	$ 5,561	$ 5,751